Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards
13 mars 2024 09h30 HE
|
Rentschler Biopharma SE
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
06 mars 2024 04h00 HE
|
Rentschler Biopharma SE
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...
Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma
06 févr. 2024 08h00 HE
|
Rentschler Biopharma SE
Senta Brandt promoted to global position of Head of TransformationGerrick Rodrigues promoted to Global Head of IT LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Feb. 06, 2024 ...
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
20 déc. 2023 07h00 HE
|
Rentschler Biopharma SE
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
07 déc. 2023 04h00 HE
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
19 sept. 2023 05h00 HE
|
Rentschler Biopharma SE
Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
13 sept. 2023 03h00 HE
|
Rentschler Biopharma SE
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support ATMP innovators at all stagesOffering comprehensive range of...
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
01 juin 2023 05h09 HE
|
Rentschler Biopharma SE
Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their ATMP site in Stevenage, UKIkarovec is developing novel gene therapies to treat...
Rentschler Biopharma Receives Worcester Business Journal 2023 Manufacturing Excellence Award
27 avr. 2023 10h00 HE
|
Rentschler Biopharma SE
Company presented with Workforce Development Award, recognizing partnership with MassBioEd and WPI to train people for biotech manufacturing positions Company honored at Worcester Business Journal...
Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status
20 mars 2023 06h00 HE
|
Rentschler Biopharma SE
Rentschler Biopharma honored with four CDMO Leadership AwardsChampion status in the Compatibility category highlights outstanding cultural fit, project management and reputationThe prestigious awards...